Navigation path

Themes
Agriculture & food
Energy
Environment
ERA-NET
Health & life sciences
Human resources & mobility
Industrial research
Information society
Innovation
International cooperation
Nanotechnology
Pure sciences
Research infrastructures
Research policy
Science & business
Science in society
Security
SMEs
Social sciences and humanities
Space
Special Collections
Transport

Countries
Countries
  Argentina
  Australia
  Austria
  Belarus
  Belgium
  Benin
  Bolivia
  Botswana
  Brazil
  Bulgaria
  Burkina Faso
  Cameroon
  Canada
  Chile
  China
  Colombia
  Croatia
  Cyprus
  Czech Republic
  Denmark
  Egypt
  Estonia
  Ethiopia
  Finland
  France
  Gambia
  Georgia
  Germany
  Ghana
  Greece
  Hungary
  Iceland
  India
  Indonesia
  Ireland
  Israel
  Italy
  Jamaica
  Japan
  Kazakhstan
  Kenya
  Korea
  Latvia
  Lichtenstein
  Lithuania
  Luxembourg
  Madagascar
  Malaysia
  Malta
  Mexico
  Montenegro
  Morocco
  Mozambique
  Namibia
  Netherlands
  New Zealand
  Nigeria
  Norway
  Panama
  Peru
  Poland
  Portugal
  Romania
  Russia
  Senegal
  Serbia
  Slovakia
  Slovenia
  South Africa
  Spain
  Sri Lanka
  Swaziland
  Sweden
  Switzerland
  Taiwan
  Tanzania
  Thailand
  Tunisia
  Turkey
  Uganda
  Ukraine
  United Kingdom
  United States
  Vietnam


   Infocentre

Last Update: 11-07-2014  
Related category(ies):
Innovation  |  Health & life sciences  |  Space  |  Nanotechnology

 

Countries involved in the project described in the article:
Czech Republic  |  Denmark  |  Finland  |  France  |  Germany  |  Greece  |  Italy  |  Sweden  |  Switzerland  |  United Kingdom
Add to PDF "basket"

Pioneering nanotech approach to help people hear

Around 50 million EU citizens are deaf or hard of hearing. The EU-funded NANOEAR project has built up knowledge and processes that could improve their ability to hear. The results include a novel nanoparticle-based system with the potential to restore hearing, repair tissue and increase performance of cochlear implants. A nano-hearing implant could be available within 10 years.

Photo of a woman trying to hear

© Kalim - Fotolia

The starting point for NANOEAR was studies suggesting that stimulating the inner ear nerve cells improves the function of cochlear implants. This can be done using nerve growth factor – a small protein. An alternative approach, also shown to improve the function of the inner ear, is to use novel genes to stimulate re-growth of the outer hair cells.

Repair and restore
Inspired by these developments, the NANOEAR team set out to create tools to repair cellular injury, restore tissue growth and induce cellular regeneration in the inner ear. Over five-years the team took huge steps towards reaching this goal, developing several nanoparticle carriers to transport therapeutic agents, such as drugs and genes, into the inner ear. They also created several so-called multifunctional nanoparticles (MFNPs) able to target selected tissue and release drugs in a controlled manner.

These MFNPs contain peptides (amino acids) to enhance internalisation to cells and transfection to nuclei. They are also invisible to the immune system so can escape detection.

“Traditional drugs are not able to pass through the tight membranes separating the middle ear from the inner ear,” explains project coordinator Dr IImari Pyykkö of the University of Tampere in Finland. “During NANOEAR we demonstrated that passage to the inner ear is in fact possible with nanoparticles that can carry drugs and target specific cells.”

The team carried out unprecedented MRI-imaging of the human inner ear by adding contrast agents to the nanoparticles, which made it possible to trace them in the body. This process gave much more detail of the ear than was previously possible.

This imaging also showed that the oval window membrane is a very effective pathway to the inner ear; not the round window as was previously thought.

A new implant for the inner ear?
Imaging and drug delivery are not the project’s only achievements. NANOEAR, which ended in October 2011, also laid the groundwork for developing a radically new cochlear implant, which is today undergoing further development in another project. It can be expected on the market within the next 10 years.

“We are currently trying to improve the cochlear implant by allowing the nerve endings to grow to the electrodes,” explains Dr Pyykkö.

NANOEAR has resulted in several patents, mainly in electrode technology and drug incorporation, and some of the partners aim to produce prototypes for human use under a new EU-funded project, known as NanoCI. Project partners are currently in the process of establishing joint ventures with the pharmaceutical industry to commercialise the nanodelivery items. The carrier system could also have many other applications within regenerative medicine.

 

Project details

  • Project acronym: NANOEAR
  • Participants: Finland (Coordinator), Germany, Sweden, Italy, Czech Republic, France, Greece, Austria, Switzerland, Denmark, UK
  • Project FP7 26556
  • Total costs: € 12 010 034
  • EU contribution: € 10 499 957
  • Duration: November 2006 - October 2011

Convert article(s) to PDF

No article selected


loading


Search articles

Notes:
To restrict search results to articles in the Information Centre, i.e. this site, use this search box rather than the one at the top of the page.

After searching, you can expand the results to include the whole Research and Innovation web site, or another section of it, or all Europa, afterwards without searching again.

Please note that new content may take a few days to be indexed by the search engine and therefore to appear in the results.

Print Version
Share this article
See also
Project web site
Project information on CORDIS






  Top   Research Information Center